Results 281 to 290 of about 66,500 (291)

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Regulation of the mechanistic target of rapamycin complex 1 (mTORC1) - nuclear hormone receptor signaling by bile acids

Journal of Hepatology, 2017
T. Moustafa, A. Zaufel, T. Eichmann, D. Kolb-Lenz, M. Trauner, P. Fickert   +5 more
openaire   +1 more source

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Clinical development and potential of photothermal and photodynamic therapies for cancer

Nature Reviews Clinical Oncology, 2020
Xing-Shu Li, Jonathan F Lovell, Juyoung Yoon   +2 more
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015

Ca-A Cancer Journal for Clinicians, 2007
Carolyn D Runowicz
exaly  

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Nature Reviews Microbiology, 2009
Lanying Du, Yuxian He, Yusen Zhou
exaly  

Therapeutic strategies to target RAS-mutant cancers

Nature Reviews Clinical Oncology, 2018
Ryan B Corcoran
exaly  

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Strategies for expanding colorectal cancer screening at community health centers

Ca-A Cancer Journal for Clinicians, 2013
exaly